Revolve Wealth Partners LLC reduced its position in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 7.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,328 shares of the medical device company’s stock after selling 178 shares during the […]
MetLife Investment Management LLC lessened its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 3.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 116,194 shares of the medical device company’s stock after selling 4,238 shares during the period. MetLife Investment […]
DexCom, Inc. (NASDAQ:DXCM – Get Rating) SVP Shelly Ramasamy Selvaraj sold 2,115 shares of the company’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $130.00, for a total transaction of $274,950.00. Following the completion of the sale, the senior vice president now owns 50,390 shares in […]
/PRNewswire/ The "The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition" report has been added to ResearchAndMarkets.com s offering..
DexCom, Inc. (NASDAQ:DXCM – Get Rating) EVP Sadie Stern sold 393 shares of the stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $121.31, for a total value of $47,674.83. Following the sale, the executive vice president now directly owns 82,466 shares of the company’s […]